ISSN: 2167-065X

Pharmacologie clinique et biopharmaceutique

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Advances in Drug Delivery: Enhancing Therapeutic Efficacy through Targeted Approaches

Krizan Molloy

The field of pharmaceutical sciences has witnessed significant advancements in recent years, particularly in the area of targeted drug delivery systems. Traditional drug delivery methods often suffer from limitations such as low drug bioavailability, systemic toxicity, and lack of specificity, leading to suboptimal therapeutic outcomes and increased side effects. However, the emergence of targeted drug delivery systems has revolutionized the pharmaceutical industry by offering enhanced drug delivery capabilities, improved therapeutic efficacy, and reduced side effects. This article provides an overview of the latest advancements in targeted drug delivery systems and their potential applications in various disease conditions.